Differences in muscle strength in parkinsonian patients affected on the right and left side

Giuseppe Frazzitta, Davide Ferrazzoli, Roberto Maestri, Roberta Rovescala, Gabriele Guaglio, Rossana Bera, Daniele Volpe, Gianni Pezzoli, Giuseppe Frazzitta, Davide Ferrazzoli, Roberto Maestri, Roberta Rovescala, Gabriele Guaglio, Rossana Bera, Daniele Volpe, Gianni Pezzoli

Abstract

Background: Muscular weakness is a frequent cause of instability that contributes to falls in Parkinson's disease (PD). Isokinetic dynamometry is a method of muscle assessment useful to measure the muscular strength giving a quantification of the weakness, but only few studies about isokinetic assessment were performed in PD. The aims of the study were to evaluate the muscle strength in PD and to investigate the differences in patients affected on the right and left side.

Methods: Knee flexor and extensor muscles strength was assessed using an isokinetic dynamometer in 25 patients in stage 3 H&Y and in 15 healthy controls. Subjects were tested in both legs at three fixed angular velocities: 90°/s, 120°/s, 180°/s.

Results: Considering the whole population of Parkinsonians, no difference in strength was observed with respect to controls. Considering the side, patients affected on the right side showed a clear tendency to be weaker than patients affected on the left side and controls.

Conclusions: PD patients affected on the right side, but not those affected on the left side, had a reduction in muscle strength as compared to controls. We postulate a central origin deficit in muscle strength in PD. It is known that dopamine transporter binding is more severely reduced in the left posterior putamen and our results suggest that the control of the muscle strength in PD is linked to the right-left hemispheric asymmetry of the functional organization of basal ganglia and with their connections to cortical motor and pre-motor areas.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Schrag A, Jahanshahi M, and Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000;69: 308–312.
    1. Molczyk L, Thigpen LP, Eickhoff J, Goldgar D, Gallagher JC. Reliability of testing the knee extensors and flexors in healthy adult women using a Cybex II isokinetic dynamometer. J Orthop Sports Phys Ther. 1991;14: 37–47.
    1. Horstmann T, Maschmann J, Mayer F, Heitkamp HC, Handel M, Dickhuth HHc. The influence of age on isokinetic torque of the upper and lower leg musculature in sedentary men. Int J Sports Med. 1999;20: 362–367.
    1. de Boer A, Boukes RJ, Sterk JC. Reliability of dynamometry in patients with a neuromuscular disorder. Eng Med. 1982;11: 169–174.
    1. Tiffreau V, Ledoux I, Eynard B, Thevenon A, Hogrel JY. Isokinetic muscle testing for weak patients suffering from neuromuscular disorders: a reliability study. Neuromuscul Disord. 2007;17: 524–531.
    1. El Mhandi L, Bethoux F. Isokinetic testing in patients with neuromuscular diseases: a focused review. Am J Phys Med Rehabil. 2013;92: 163–178. 10.1097/PHM.0b013e31826ed94c
    1. Durmus B, Baysal O, Altinayar S, Altay Z, Ersoy Y, Ozcan C. Lower extremity isokinetic muscle strength in patients with Parkinson’s disease. J Clin Neurosci. 2010; 17: 893–896. 10.1016/j.jocn.2009.11.014
    1. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56: 33–39.
    1. Cano-de-la-Cuerda R, Pérez-de-Heredia M, Miangolarra-Page JC, Muñoz-Hellín E, Fernández-de-Las-Peñas C. Is there muscular weakness in Parkinson's disease? Am J Phys Med Rehabil. 2010;89: 70–76. 10.1097/PHM.0b013e3181a9ed9b
    1. Kakinuma S, Nogaki H, Pramanik B, Morimatsu M. Muscle weakness in Parkinson's disease: isokinetic study of the lower limbs. Eur Neurol. 1998;39: 218–222.
    1. Nallegowda M, Singh U, Handa G, Khanna M, Wadhwa S, Yadav SL, et al. Role of sensory input and muscle strength in maintenance of balance, gait, and posture in Parkinson's disease: a pilot study. Am J Phys Med Rehabil. 2004;83: 898–908.
    1. Corcos DM, Chen CM, Quinn NP, McAuley J, Rothwell JC. Strength in Parkinson's disease: relationship to rate of force generation and clinical status. Ann Neurol. 1996;39: 79–88.
    1. Inkster LM, Eng JJ, MacIntyre DL, Stoessl AJ. Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair. Mov Disord. 2003;18: 157–162.
    1. Edström L. Selective changes in the sizes of red and white muscle fibres in upper motor lesions and Parkinsonism. J Neurol Sci. 1970;11: 537–550.
    1. Rossi B, Siciliano G, Carboncini MC, Manca ML, Massetani R, Viacava P, et al. Muscle modifications in Parkinson's disease: myoelectric manifestations. Electroencephalogr Clin Neurophysiol. 1996;101: 211–218.
    1. Moreno Catalá M, Woitalla D, Arampatzis A. Central factors explain muscle weakness in young fallers with Parkinson's disease. Neurorehabil Neural Repair. 2013;27: 753–759. 10.1177/1545968313491011
    1. Glendinning DS, Enoka RM. Motor unit behavior in Parkinson's disease. Phys Ther. 1994;74: 61–70.
    1. Cronin-Golomb A. Parkinson's disease as a disconnection syndrome. Neuropsychol Rev. 2010;20: 191–208. 10.1007/s11065-010-9128-8
    1. Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging. 2004;25: 19–23.
    1. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318: 121–134.
    1. Kempster PA, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry. 1989;52: 72–76.
    1. Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med. 1998;39: 1143–1148.
    1. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn. 2000;42: 183–200.
    1. Scherfler C, Seppi K, Mair KJ, Donnemiller E, Virgolini I, Wenning GK et al. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease. Brain. 2012;135: 3348–3354. 10.1093/brain/aws253
    1. Barrett MJ, Wylie SA, Harrison MB, Wooten GF (2011) Handedness and motor symptom asymmetry in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2011;82: 1122–1124. 10.1136/jnnp.2010.209783
    1. Frazzitta G, Pezzoli G, Bertotti G, Maestri R. Asymmetry and freezing of gait in parkinsonian patients. J Neurol. 2013;260: 71–76. 10.1007/s00415-012-6585-4

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi